Lensar (LNSR) Common Equity (2019 - 2026)
Lensar (LNSR) posted quarterly Common Equity of $10.8 million for Q1 2026, up 148.73% year-over-year from $4.3 million in Q1 2025, and up 141.47% quarter-over-quarter from -$26.0 million in Q4 2025.
Lensar (LNSR) Common Equity (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Common Equity for 8 consecutive years, with $10.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 148.73% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $10.8 million (up 148.73% YoY), while the FY2025 annual figure was -$26.0 million, down 635.15% from the prior year.
- Common Equity rose to $10.8 million in Q1 2026 per LNSR's latest filing, from -$26.0 million in the prior quarter.
- Across five years, Common Equity topped out at $49.8 million in Q1 2022 and bottomed at -$26.0 million in Q4 2025.
- Historically, Common Equity has averaged $18.7 million across 5 years, with a median of $31.8 million in 2024.
- Annual changes were most pronounced in 2025 — Common Equity plunged 635.15% — and 2026, when it soared 148.73%.
- Lensar's Common Equity stood at $42.0 million in 2022, then slipped by 20.38% to $33.4 million in 2023, then tumbled by 85.46% to $4.9 million in 2024, then slumped by 635.15% to -$26.0 million in 2025, then soared by 141.47% to $10.8 million in 2026.
- Business Quant data shows LNSR's Common Equity at $10.8 million in Q1 2026, -$26.0 million in Q4 2025, and -$25.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Lensar | 103.79 Mn | 90.22 Mn | 9.78 Mn | 14.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.91 Mn |
| Mar 31, 2026 | 10.79 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Sep 30, 2025 | -25.91 Mn |
| Jun 30, 2025 | -23.05 Mn |
| Mar 31, 2025 | -22.14 Mn |
| Dec 31, 2024 | 4.86 Mn |
| Sep 30, 2024 | 22.74 Mn |
| Jun 30, 2024 | 23.65 Mn |
| Mar 31, 2024 | 31.84 Mn |
| Dec 31, 2023 | 33.43 Mn |
| Sep 30, 2023 | 36.38 Mn |
| Jun 30, 2023 | 32.69 Mn |
| Mar 31, 2023 | 39.44 Mn |
| Dec 31, 2022 | 41.98 Mn |
| Sep 30, 2022 | 42.58 Mn |
| Jun 30, 2022 | 44.90 Mn |
| Mar 31, 2022 | 49.81 Mn |
| Dec 31, 2021 | 54.88 Mn |
| Sep 30, 2021 | 57.05 Mn |